IPO - Instil Bio, Inc.

Form Type: 424B5

Filing Date: 2025-03-31

Corporate Action: Ipo

Type: New

Accession Number: 000119312525067364

Filing Summary: Instil Bio, Inc. has filed a prospectus supplement relating to the offering of an aggregate of up to $100,000,000 of its common stock through an Open Market Sale Agreement with Jefferies LLC. The company intends to use the net proceeds from the offering primarily for general corporate purposes, which may include research and development costs, strategic acquisitions, and working capital needs. The common stock offered is listed on the Nasdaq under the symbol 'TIL', with the last reported sale price being $19.36 as of March 27, 2025. The document outlines the risks associated with investing in the common stock and highlights that, as an emerging growth company, Instil Bio is subject to reduced public company reporting requirements.